Global Precision Medicine Market Report 2020 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Precision Medicine industry.
Global artificial intelligence (ai) in precision medicine market size is expected to reach $6.86 Bn by 2028 at a rate of 30.4%, segmented as by component, hardware, software, service
Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.
Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual.
The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. Get more details @ https://goo.gl/y9VxzK
This report focuses on the global Precision Medicine Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Medicine Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Global Precision medicine Market Information by Ecosystem (diagnostic companies, clinical laboratories), by Sub Markets (Companion diagnostic, biomarker based test), by Therapeutics (cardiovascular disease, central nervous system) - Forecast to 2027
Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.
The global oncology precision medicine market was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030 For more info - https://straitsresearch.com/report/oncology-precision-medicine-market
The report Personalized Medicine Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The global brachytherapy market is projected to be worth USD 548.8 Million by 2027, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer.
The Veterinary Medicine Market Report provides an exhaustive analysis of the growth drivers, current trends, restraining forces, and opportunities present in the market.
AI in Precision Medicine Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision), Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others), and Region (North America, Europe, Asia Pacific, RoW) – Global Forecast to 2027
The global nucleic acid labeling market size was USD 2.16 billion in 2022 and is expected to reach USD 4.32 billion in 2032, and register a revenue CAGR of 8% during the forecast period. Rising demand for personalized medicine, Genomics research, and improvements in Molecular Diagnostics are major factors driving the market revenue growth. To visualize and analyze Gene Expression, protein interactions, and other biological processes, nucleic acids must be labeled with fluorescent, radioactive, or other tags. This is known as nucleic acid labeling.
The global Research Antibodies Market size was USD 1.41 Billion in 2021 and is expected to register a revenue CAGR of 4.9% during the forecast period, according to latest analysis by Emergen Research. An increase in research and development (R&D) activities related to the fields of neurobiology, oncology and stem cell research, the increasing incidence of cancer and infectious diseases, and the growing demand from the biopharmaceutical industry for these antibiotics are the main drivers of the market. increase the revenue. Research antibodies are antibodies that can bind to specific molecules, which are used as basic detection tools needed in scientific research and are also important tools for studying protein function in cell.
According to P&S Intelligence, the precision medicine market generated $203.5 billion in 2019 and it is expected to reach $738.8 billion by 2030, progressing at a CAGR of 12.1% during the forecast period (2020–2030). This growth can be driven by the rising government support, escalating awareness regarding personalized treatments, rising number of approved personalized medications, increasing use of artificial intelligence (AI) in clinical trials related to precision medications, surging number of regulatory approvals, soaring cases of chronic and genetic diseases, and flourishing medical tourism industry.
The global artificial intelligence (AI) in precision medicine market is expected to grow from $1.41 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 29.3%.
Request for sample research report at https://precisionbusinessinsights.com/request-sample?product_id=17135 The global regenerative medicine market size was valued US$ 8425 Mn in the year 2020 and is anticipated to grow at US$ 21871 Mn till 2027 witnessing a CAGR of 14.6% over the forecast period 2021-2027. Market players took initiatives for increasing finance for R&D of regenerative medicine is projected to support the market growth. Furthermore industries are working together to reinforce their R&D capabilities for the developing as well as commercializing pioneering therapies for making
DecisionDatabases.com, a market research firm adds a report Global Computational Medicine Industry 2016 Market Research Report to its repository. The report gives a detailed account of the industry - Sales, Revenue Size, Share, Exports, Imports, and Production Volume etc.
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.
Non-Oncology Precision Medicine market is segmented by Ecosystem, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.
Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
The global Bioinformatics Market is primarily driven by the increasing adoption of next-generation sequencing (NGS) technologies and rising focus on precision medicine.
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
The Global Precision Oncology market research report provides an insightful analysis of the current market, along with a futuristic perspective on the growth of the market.
According to Market Research Future (MRFR) Analysis – US Personalized Medicine Market is growing at a CAGR of 7.5% during the forecast period of 2017 to 2023. The research report includes Industry updates, size, share, demand analysis, competitive landscape, market attractiveness
Electroceuticals/Bioelectric Medicine Market is expected to grow in upcoming years due to factors such as rise in geriatric population across the world, increase in regulatory approvals for new and advanced electroceuticals and rise in investment and funds for the development in new therapies.
The latest report by Precision Business Insights, titled “Personalized Medicine Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.
The global medical dynamometer market is predicted to grow at a CAGR of 5.76% over the forecast period of 2024 to 2032. Get more insights into our latest blog
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030. Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention.
The India Rapid IVD Kits Industry is estimated at USD 1.71 billion in 2024, with expectations to reach USD 2.34 billion by 2029, showcasing a robust CAGR of 6.58% during the forecast period (2024-2029).
The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441
According to #TechSci Research report, Global Precision Medicine Market, was valued USD66.85 billion in 2020 and is expected to reach USD125.67 billion, growing at CAGR of 10.65% during the forecast period. Gain More Insight: https://bit.ly/3Df5kr2 Get Sample Report: https://bit.ly/3kneqJG Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
The global cell therapy market size was valued at USD 8.1 billion in 2021 and is estimated to reach USD 23.9 billion by 2030, growing at a CAGR of 14.5% over the forecast period. The cell therapy market has witnessed remarkable growth due to its potential in treating various diseases. This innovative approach involves using living cells to repair, replace, or enhance tissue function.
Global Market Insights Inc. presents the Genomics Services Market provides a detailed overview of major drivers, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with estimates and forecast of revenue.
Global Market Insights add New Global Mice Model Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region.
The global Process Analyzer market is expected to grow from USD 7.8 billion in 2023 to USD 9.3 billion by 2028, registering a CAGR of 3.6%. The demand for exceptionally precise process analyzers is escalating within the expanding domains of drug development, bioprocessing, and personalized medicine. These analytical instruments are indispensable in research, development, and pharmaceutical manufacturing, guaranteeing the highest levels of quality. Browse 120 market data Tables and 40 Figures spread through 200 Pages and in-depth TOC on "Process Analyzer Market - Global Forecast to 2028"
The drone logistics and transportation market is projected to grow from USD 534 million in 2022 to USD 17,881 million by 2030, at a CAGR of 55.1% from 2022 to 2030.
Global Market Insights Inc. presents the Mice Model Market provides a detailed overview of major drivers, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with estimates and forecast of revenue.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
The rising prevalence of Leukemia and Multiple myeloma and the increasing awareness among patients and healthcare professionals about initial diagnosis are driving the demand for the market.
Global Biomarkers Market is a rapidly growing market, driven by technological advancements, changing consumer preferences, and regulatory policies. The market is highly competitive and is segmented by product type, application, and geography
According to the latest research report by IMARC Group, The global genotyping market reached a value of US$ 14.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 36.75 Billion by 2027, exhibiting a CAGR of 15.60% during 2022-2027. More Info:- https://www.imarcgroup.com/genotyping-market
The digital twins in healthcare market is rapidly expanding, revolutionizing the way medical professionals approach patient care and treatment. Digital twins are virtual replicas of physical assets, entities, or processes that provide real-time insights and analytics, and in healthcare, they are being used to create personalized models of individual patients for enhanced diagnosis and treatment planning.